Is a wide range bactericide antibiotic that has an effect on most of the pathogens that produce mastitis, such as: S. uberis, E. coli and Staphylococcus resistant to penicillin. This activity is due to the combination of cephalexin and kanamycin.
Due to its synergism, CEFALEX-K is the antibiotic preferred for the treatment of mastitis, given that it attacks the following pathogens: Streptococcus, Corynebacterium, Proteus, Shigella, Staphylococcus, E. coli, Salmonella, Klebsiella, Pasteurella and some other enterobacteria.
As CEFALEX-K is a unique combination that maintains great synergism. It provides two treatments that cure most types of mastitis.
CEFALEX-K offers great activity against the most common pathogens that cause mastitis. It is the medication that has the widest range against this disease.